BIROLINI, GIULIA
BIROLINI, GIULIA
Dipartimento di Bioscienze
ADAM10 hyperactivation acts on piccolo to deplete synaptic vesicle stores in Huntington's disease
2021 F. Cozzolino, E. Vezzoli, C. Cheroni, D. Besusso, P. Conforti, M. Valenza, I. Iacobucci, V. Monaco, G. Birolini, M. Bombaci, A. Falqui, P. Saftig, R.L. Rossi, M. Monti, E. Cattaneo, C. Zuccato
CHOLESTEROL DYSFUNCTION IN HUNTINGTON¿S DISEASE: WORKING TOWARD A THERAPEUTICAL APPROACH
2021 G. Birolini
Cholesterol-laden brain-permeable nanoparticles support long-lasting cognitive recovery and motor amelioration in the slow-progressing zQ175DN mouse model of Huntington’s Disease
2022 G. Birolini, M. Valenza, I. Ottonelli, F. Talpo, L. Minoli, A. Cappelleri, M. Bombaci, C. Caccia, V. Leoni, A. Passoni, M. Favagrossa, M.R. Nucera, L. Colombo, S. Paltrinieri, R. Bagnati, J. Thomas Duskey, R. Caraffi, M. Angela Vandelli, F. Taroni, M. Salmona, E. Scanziani, G.R. Biella, B. Ruozi, G.F. Tosi, E. Cattaneo
Chronic cholesterol administration to the brain supports complete and long-lasting cognitive and motor amelioration in Huntington's disease
2023 G. Birolini, M. Valenza, I. Ottonelli, F. Talpo, L. Minoli, A. Cappelleri, M. Bombaci, C. Caccia, C. Canevari, A. Trucco, V. Leoni, A. Passoni, M. Favagrossa, M.R. Nucera, L. Colombo, S. Paltrinieri, R. Bagnati, J.T. Duskey, R. Caraffi, M.A. Vandelli, F. Taroni, M. Salmona, E. Scanziani, G. Biella, B. Ruozi, G. Tosi, E. Cattaneo
Dose-dependent and disease-modifying effects of striatal infusion of cholesterol in Huntington{\textquotesingle}s disease
2020 G. Birolini, M. Valenza, E. Dipaolo, E. Vezzoli, F. Talpo, C. Maniezzi, C. Caccia, V. Leoni, V.D. Bocchi, P. Conforti, E. Sogne, L. Petricca, C. Cariulo, M. Verani, A. Caricasole, A. Falqui, G.R. Biella, E. Cattaneo
Efficacy of Cholesterol Nose-to-Brain Delivery for Brain Targeting in Huntington's Disease
2020 A. Passoni, M. Favagrossa, L. Colombo, R. Bagnati, M. Gobbi, L. Diomede, G. Birolini, E. Di Paolo, M. Valenza, E. Cattaneo, M. Salmona
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington disease
2020 G. Birolini, M. Valenza, I. Ottonelli, A. Passoni, M. Favagrossa, J. T Duskey, M. Bombaci, M. Angela Vandelli, L. Colombo, R. Bagnati, C. Caccia, V. Leoni, F. Taroni, F. Forni, B. Ruozi, M. Salmona, G. Tosi, E. Cattaneo
Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease
2021 G. Birolini, M. Valenza, I. Ottonelli, A. Passoni, M. Favagrossa, J.T. Duskey, M. Bombaci, M.A. Vandelli, L. Colombo, R. Bagnati, C. Caccia, V. Leoni, F. Taroni, F. Forni, B. Ruozi, M. Salmona, G. Tosi, E. Cattaneo
Nanoparticles for transport across the blood-brain barrier
2022 E. Cattaneo, M. Valenza, G. Birolini, G. Tosi, B. Ruozi, F. Forni, P. Linciano, M.A. Vandelli
SREBP2 delivery to striatal astrocytes normalizes transcription of cholesterol biosynthesis genes and ameliorates pathological features in Huntington’s Disease
2020 G. Birolini, G. Verlengia, F. Talpo, C. Maniezzi, L. Zentilin, M. Giacca, P. Conforti, C. Cordiglieri, C. Caccia, V. Leoni, F. Taroni, G. Biella, M. Simonato, E. Cattaneo, M. Valenza
SREBP2 gene therapy targeting striatal astrocytes ameliorates Huntington's disease phenotypes
2021 G. Birolini, G. Verlengia, F. Talpo, C. Maniezzi, L. Zentilin, M. Giacca, P. Conforti, C. Cordiglieri, C. Caccia, V. Leoni, F. Taroni, G. Biella, M. Simonato, E. Cattaneo, M. Valenza
Striatal infusion of cholesterol promotes dose-dependent behavioral benefits and exerts disease-modifying effects in Huntington's disease mice
2020 G. Birolini, M. Valenza, E. Di Paolo, E. Vezzoli, F. Talpo, C. Maniezzi, C. Caccia, V. Leoni, F. Taroni, V.D. Bocchi, P. Conforti, E. Sogne, L. Petricca, C. Cariulo, M. Verani, A. Caricasole, A. Falqui, G. Biella, E. Cattaneo
The translational potential of cholesterol-based therapies for neurological disease
2023 M. Valenza, G. Birolini, E. Cattaneo